Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2019

Open Access 01-12-2019 | Opioids | Research

Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention

Authors: Alexis Cooke, Haneefa Saleem, Saria Hassan, Dorothy Mushi, Jessie Mbwambo, Barrot Lambdin

Published in: Addiction Science & Clinical Practice | Issue 1/2019

Login to get access

Abstract

Background

In Dar es Salaam Tanzania, the first opioid treatment program (OTP) in Sub-Saharan Africa, had very high rates of enrollment of people who use drugs (PWUD) but low rates of antiretroviral therapy (ART) initiation among HIV-positive patients. The integrated methadone and anti-retroviral therapy (IMAT) intervention was developed to integrate HIV services into the OTP clinic. The objective of this paper is to better understand the contextual factors that influence the effectiveness of IMAT implementation using the consolidated framework for implementation research (CFIR).

Methods

Semi-structured, in-depth interviews were conducted with 35 HIV-positive OTP patients and 8 OTP providers at the Muhimbili National Hospital OTP clinic 6-months after IMAT implementation. Providers were asked about their reactions to and opinions of the IMAT intervention including its implementation, their role in patient education, intervention procedures, and ART dispensing. Interviews with patients focused on their experiences with the IMAT intervention and adapting to the new protocol. Analysis of interview data was guided by the CFIR.

Results

The CFIR constructs found to be driving forces behind facilitating or impeding IMAT implementation were: intervention characteristics (e.g. complexity, adaptability and evidence related to IMAT), outer setting (e.g. patient needs and resources), and inner setting (e.g. compatibility of IMAT and available resources for IMAT). The most significant barrier to implementation identified in interviews was availability of resources, including workforce limitations and lack of space given patient load. OTP providers and patients felt the design of the IMAT intervention allowed for adaptability to meet the needs of providers and patients.

Conclusions

Understanding the contextual factors that influence implementation is critical to the success of interventions that seek to integrate HIV services into existing programs for key populations such as PWUD. Approximately 4 months after IMAT implementation, the OTP clinic adopted a ‘test-and-treat’ model for HIV-positive PWUD, which significantly impacted clinic workload as well as the care context. In this study we highlight the importance of intervention characteristics and resources, as key facilitators and barriers to implementation, that should be actively integrated into intervention protocols to increase implementation success. Similar interventions in other low-resource settings should address the ways intervention characteristics and contextual factors, such as adaptability, complexity and available resources impact implementation in specific care contexts.
Literature
1.
go back to reference WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users—2012 revision. World Health Organization; 2012. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users—2012 revision. World Health Organization; 2012.
2.
go back to reference Batkis MF, Treisman GJ, Angelino AF. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies. AIDS Patient Care STDs. 2010;24:15–22.CrossRef Batkis MF, Treisman GJ, Angelino AF. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies. AIDS Patient Care STDs. 2010;24:15–22.CrossRef
3.
go back to reference Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14:731–47.CrossRef Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14:731–47.CrossRef
4.
go back to reference TACAIDS Z, NBS OCGS I. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12. Dar Es Salaam Tanzan Dar Es Salaam Tanzan Tanzan Comm AIDS TACAIDS Zanzibar AIDS Comm ZAC Natl Bur Stat NBS Off Chief Gov Stat OCGS ICF Int; 2013. TACAIDS Z, NBS OCGS I. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12. Dar Es Salaam Tanzan Dar Es Salaam Tanzan Tanzan Comm AIDS TACAIDS Zanzibar AIDS Comm ZAC Natl Bur Stat NBS Off Chief Gov Stat OCGS ICF Int; 2013.
5.
go back to reference Global AIDS Response Country Progress Report. Tanzania Commission for AIDS; 2014. Global AIDS Response Country Progress Report. Tanzania Commission for AIDS; 2014.
7.
go back to reference Tran OC, Bruce RD, Masao F, Ubuguyu O, Sabuni N, Mbwambo J, et al. Implementation and operational research: linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. JAIDS J Acquir Immune Defic Syndr. 2015;69:e43–8.CrossRef Tran OC, Bruce RD, Masao F, Ubuguyu O, Sabuni N, Mbwambo J, et al. Implementation and operational research: linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. JAIDS J Acquir Immune Defic Syndr. 2015;69:e43–8.CrossRef
10.
go back to reference Dedoose Version 7.0.23. Web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles, CA: SocioCultural Research Consultants, LLC; 2016. Dedoose Version 7.0.23. Web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles, CA: SocioCultural Research Consultants, LLC; 2016.
14.
go back to reference Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014–28.CrossRef Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014–28.CrossRef
Metadata
Title
Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention
Authors
Alexis Cooke
Haneefa Saleem
Saria Hassan
Dorothy Mushi
Jessie Mbwambo
Barrot Lambdin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2019
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-019-0133-9

Other articles of this Issue 1/2019

Addiction Science & Clinical Practice 1/2019 Go to the issue